Dr. Bhatt has received research grants from Abbott, Amarin, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Idorsia, Ironwood, Ischemix, Lilly, Medtronic, PhaseBio, Pfizer, Regeneron, Roche, Sanofi Aventis and the Medicines Company.
Brigham and Women's Hospital Heart & Vascular Center, and Harvard Medical School
|Program Name||Last Air Date||Hosts/Guests|
|REDUCE-IT Trial Studying Icosapent Ethyl: An In-Depth Review of USA Dataset with Commentary||03/30/2020|
|New Opportunities to Improve Management of Patients with or at High Risk of ASCVD Events||02/01/2020|
|New Options & Strategies for CV Risk Reduction in Diabetes: What the Data Tell Us|
|New Opportunities to Improve Management of Patients with or at High Risk of ASCVD Events|
You need to be logged in to save this episode to a playlist.